Latest News about MRK
Recent news which mentions MRK
From Benzinga
Merck reports positive results for blockbuster cancer drug in treating non-small cell lung cancer
October 10, 2023
From MarketWatch
From InvestorPlace
From Benzinga
From Benzinga
No Merck's COVID-19 Pill - US Government Ceases Free Distribution
October 05, 2023
From Benzinga
Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares
October 04, 2023
From Benzinga
2 Magnificent Growth Stocks to Buy Right Now
October 04, 2023
From Motley Fool
Teva partnership with Sanofi ‘will pay dividends,’ analyst says
October 04, 2023
From MarketWatch
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
October 03, 2023
From Benzinga
From Benzinga
Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today?
October 03, 2023
From Benzinga
Medicare drug price negotiations move forward with all drugmakers participating, White House says
October 03, 2023
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
From Benzinga
This fund shows that industry expertise can help you make a lot of money in the stock market
October 02, 2023
From MarketWatch
These Market Experts See a Downturn Coming: 2 Defensive Index Funds That Are Proven Moneymakers to Buy Now
October 01, 2023
From Motley Fool
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 29, 2023
From Benzinga
As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment
September 29, 2023
From MarketWatch
Amazon Web Services Now Offers Generative AI Tools For Businesses, Catches Up With Microsoft Azure, Google Cloud
September 28, 2023
From Benzinga
From Benzinga
Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine
September 27, 2023
From Benzinga
Merck’s COVID antiviral may be linked to virus mutations, study finds
September 25, 2023
From MarketWatch
With Cancer Immunotherapy Market Set To Grow At Double-Digit CAGR Till 2032, This Company Plans To Ride The Wave Through Treatments For Complex Cancers
September 25, 2023
From Benzinga
Why Is Seagen Stock Trading Higher Today?
September 22, 2023
From Benzinga
Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer
September 22, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.